Medipattern Corp. : Medipattern to Report First Quarter Results Under New IFRS Guidelines

TORONTO, ONTARIO--(Marketwire -12/01/11)- Attention: Business/Financial Editors:

The Medipattern Corporation ("Medipattern") (TSX-V: - ), a pioneer in the development of medical imaging software solutions that help medical practitioners to better understand lesions and critical anatomy, today announced that its first quarter results for fiscal 2012 ("Q1 2012") will be completed and filed by December 29, 2011. Q1 2012 is the first reporting period for the Company under the new International Financial Reporting Standards ("IFRS") requirements. The TSX and Ontario Securities Commission granted issuers an additional 30 days to prepare their first interim financial and operating results under these new guidelines. Following Q1 2012, the Company will resume its normal course requirements for interim and annual financial reporting.

About The Medipattern Corporation:

- ) is a pioneer in the development of imaging software solutions that help medical practitioners to better understand lesions and critical anatomy. Medipattern uses its Cadenza™ technology to process images, finding the salient region of interest and presenting them in 2D and 3D formats that enhance the reader's perception. For more information, please visit the Company's website: .

B-CAD® and Medipattern® are a registered trademarks of The Medipattern Corporation. Visualize:Vascular™, Cadenza™ and B-CADmri™ are trademarks of The Medipattern Corporation.

Forward-looking statements

This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates,'' "believes,'' "estimates,'' "expects,'' "plans,'' "intends,'' "potential'', and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at ). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact:

The Medipattern Corporation
Jeff Collins
CEO
[phone] ext. 224
[e-mail]
Spinnaker Capital Markets Inc.
Kevin O'Connor
[phone] x226
[e-mail]